Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin® Outcomes Registry and Experience
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin® Outcomes Registry and Experience
Authors
Keywords
Clinical response, Daptomycin, EU-CORE, Gram-positive infections, High dose, Infectious diseases, Safety
Journal
ADVANCES IN THERAPY
Volume 32, Issue 12, Pages 1192-1205
Publisher
Springer Nature
Online
2015-11-26
DOI
10.1007/s12325-015-0267-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
- (2015) Francesc Gudiol et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis
- (2013) Manuela Carugati et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
- (2013) Anthony M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Daily Daptomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
- (2013) Natascia Corti et al. CHEMOTHERAPY
- Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2013) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
- (2013) Kyle P. Murray et al. CLINICAL INFECTIOUS DISEASES
- Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial
- (2013) Alexander Konychev et al. DRUGS & AGING
- Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations
- (2013) Chun-Wen Cheng et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetic/pharmacodynamic evaluation of the efficacy and safety of daptomycin against Staphylococcus aureus
- (2013) Rachel L. Soon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin: The role of high-dose and combination therapy for Gram-positive infections
- (2013) Ian M. Gould et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin for the treatment of infective endocarditis: results from a European registry
- (2012) P. M. Dohmen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin as supportive treatment option in patients developing mediastinitis after open cardiac surgery
- (2012) Florian Weis et al. Journal of Cardiothoracic Surgery
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Eficacia y seguridad de daptomicina en dosis elevadas (≥ 8mg/kg/día)
- (2011) Jorge Parra-Ruiz et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Daptomycin: evaluation of a high-dose treatment strategy
- (2011) Gary Wu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD
- (2011) D. Khadzhynov et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
- (2011) E. A. King et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical experience with daptomycin in Europe: the first 2.5 years
- (2011) A. Gonzalez-Ruiz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
- (2011) Ravina Kullar et al. PHARMACOTHERAPY
- High-dose daptomycin in documented Staphylococcus aureus infections
- (2010) Matteo Bassetti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
- (2009) Pamela A Moise et al. ANNALS OF PHARMACOTHERAPY
- Early Experience with High‐Dosage Daptomycin for Prosthetic Infections
- (2009) Francesco G. De Rosa et al. CLINICAL INFECTIOUS DISEASES
- Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program
- (2009) D. A. Figueroa et al. CLINICAL INFECTIOUS DISEASES
- Documento de consenso sobre el tratamiento de la bacteriemia y la endocarditis causada por Staphylococcus aureus resistente a la meticilina
- (2009) Francisco Gudiol et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria
- (2008) D. E. Katz et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started